Indeed, LPAR1 is crucial in bone metastasis of breast carcinoma, LPAR2 promotes colorectal cancer [102] and aggressiveness of ovarian cancer cells, whereas LPAR3 enhances migration of hepatoma cells ([103] and refer therein). Here, LPAR3 is linked to breast carcinoma.